Kaynakça var.

The Role of Epigenetics in Cancer Trygve O. Tollefsbol* Section 1: DNA Methylation and Cancer 2. DNA Hypomethylation in Cancer Peter L. Molloy* 3. DNA Hypermethylation in Oncogenesis J. Tyson DeAngelis, Joel B. Berletch, Lucy G. Andrews, and Trygve O. Tollefsbol* 4. Imprinting Alterations in Tumorigenesis Jeremiah Bernier-Latmani and Phillip Shaw* 5. Proteins that Modulate DNA Methylation Aberrations in Cancer Sabrina L. Walthall, Sharla M.O. Phipps, Lucy G. Andrews, and Trygve O. Tollefsbol* 6. The Role of DNA Methylation in Cancer Progression Sang-Woon Choi* and Simonetta Friso Section 2: Histone Modifications in Cancer 7. Alterations in Histone Acetylation in Tumorigenesis Sabita N. Saldanha and Trygve O. Tollefsbol* 8. Histone Methylation and the Initiation of Cancer Shi Huang* 9. The Role of Sirtuins in Aging and Tumorigenesis Xiaohong Zhang, Tung I. Hseih, Santo V. Nicosia, and Wenlong Bai* 10. Proteins that Alter Histone Modifications in Cancer Ada Ao and Jianrong Lu* 11. Dietary and Environmental Influences on Histone Modifications in Cancer Sabita N. Saldanha, Vijayalakshmi Nandakumar, Ada Elgavish, and Trygve O. Tollefsbol* Section 3: Other Epigenetic Aspects of Cancer 12. Noncoding RNAs in Cancer Maciej Szymanski* and Jan Barciszewski 13. Cancer-linked DNA Hyper- and Hypomethylation: Chromosome Positional Effects Melanie Ehrlich* 14. Chromatin Remodeling and Cancer Sari Pennings* and Richard R. Meehan 15. Poly-ADP-ribosylation in Cancer Rajeshwar N. Sharan* 16. Polycomb Group Proteins in Tumorigenesis Hanneke E.C. Niessen and Jan Willem Voncken* 17. Cancer and Aging: The Epigenetic Connection Craig A. Cooney* Section 4: Epigenetics in the Diagnosis, Prognosis and Therapy of Cancer 18. DNA Methylation in Tumor Diagnosis Kavitha Ramachandran, Edna Gordian and Rakesh Singal* 19. DNA Methylation Profiles as Prognostic Markers for Cancer Sam Thiagalingam* and Panagiotis Papageorgis 20. Diagnosing Cancer Using Histone Modification Analysis Mukesh Verma* and Deepak Kumar 21. Histone Modifications in Cancer Biology and Prognosis Matthew A. McBrian, David B. Seligson, and Siavash K. Kurdistani* 22. Histone Deacetylase Inhibitors in Cancer Therapy Aaron M. Sargeant, Samuel K. Kulp, Yen-Shen Lu, Ann-Lii Cheng, and Ching-Shih Chen* 23. Methylation Changes in Neoplasia: Diagnostic and Therapeutic Implications Eleftheria Hatzimichael, Justin Stebbing, and Tim Crook* 24. Clinical Trials and Approved Drugs for Epigenetic Cancer Therapy Debby M.E.I. Hellebrekers and Manon van Engeland* Section 5: Future Directions 25. Future Directions in Epigenetic Cancer Research Jacob Peedicayil*